InMode Ltd. - Ordinary Shares (INMD)
Healthcare › Electromedical & Electrotherapeutic Apparatus
Price History
Feb 9, 2026 — Mar 30, 2026Investment Snapshot
- Trading 29% below Graham Number ($18.96) — significant margin of safety
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 13.7% — below-average profitability
- Revenue declining 6% annually
InMode Ltd. - Ordinary Shares (INMD) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the NASDAQ , with a market capitalisation of $849 million . Key value metrics: P/E ratio 9.0, P/B ratio 1.24, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
InMode Ltd. - Ordinary Shares — Fundamental Analysis Summary
InMode Ltd. - Ordinary Shares (INMD) is trading 29% below its Graham Number of $18.96 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 9.0x.
On financial health, INMD shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and modest return on equity of 13.7% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.12.
StockPik's composite Value Score for INMD is 79/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
INMD reports a high gross margin of 78.5% (sector average: 33.5%) and a strong operating margin of 23.0%.
INMD shows revenue declining at 6% year-over-year, with earnings declining at 48%.